Sabine Meyenburg

Title: The Innovative Contributions of Sabine Meyenburg

Introduction

Sabine Meyenburg is a notable inventor based in Inzlingen, Germany. She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative treatments for skin, nail, and mucosal diseases. Her work exemplifies the intersection of science and practical application in healthcare.

Latest Patents

Meyenburg holds a patent for a unique formulation titled "Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides." This pharmaceutical foam composition is substantially free of ethanol and comprises pimecrolimus in a carrier vehicle made up of a mixture of oily solvents, which constitutes at least 40% of the total weight of the composition. This formulation is designed to treat various skin, nail, and mucosal diseases effectively.

Career Highlights

Throughout her career, Sabine Meyenburg has worked with prominent companies in the pharmaceutical industry, including Meda Pharma Sarl and Meda Pharma S.à.r.l. Her experience in these organizations has allowed her to refine her expertise and contribute to the development of innovative healthcare solutions.

Collaborations

Meyenburg has collaborated with notable professionals in her field, including Meir Eini and Doron Friedman. These partnerships have facilitated the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Sabine Meyenburg's contributions to pharmaceutical innovations highlight her dedication to improving healthcare through effective treatments. Her patent and collaborations reflect her commitment to advancing medical science and enhancing patient care.